These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 639170)

  • 1. Biological fate of butylated hydroxytoluene (BHT): subcellular distribution of BHT in rat liver.
    Nakagawa Y; Ikawa M; Hiraga K
    Chem Pharm Bull (Tokyo); 1978 Feb; 26(2):374-8. PubMed ID: 639170
    [No Abstract]   [Full Text] [Related]  

  • 2. Biological fate of butylated hydroxytoluene (BHT); binding in vitro of BHT to liver microsomes.
    Nakagawa Y; Hiraga K; Suga T
    Chem Pharm Bull (Tokyo); 1979 Feb; 27(2):480-5. PubMed ID: 445683
    [No Abstract]   [Full Text] [Related]  

  • 3. Cyclic metabolic pathway of a butylated hydroxytoluene by rat liver microsomal fractions.
    Chen C; Shaw YS
    Biochem J; 1974 Dec; 144(3):497-501. PubMed ID: 4468819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological fate of butylated hydroxytoluene (BHT); binding in vivo of BHT to macromolecules of rat liver.
    Nakagawa Y; Hiraga K; Suga T
    Chem Pharm Bull (Tokyo); 1979 Feb; 27(2):442-6. PubMed ID: 445679
    [No Abstract]   [Full Text] [Related]  

  • 5. Early interaction of radioactive butylated hydroxytoluene with protein factors of varying stability in rat liver, related to the onset of sequential biochemical changes leading to the induction of drug-metabolizing enzymes and liver enlargment.
    Scully MF; Bray PJ; Nievel JG
    Biochem Soc Trans; 1976; 4(3):526-8. PubMed ID: 1001718
    [No Abstract]   [Full Text] [Related]  

  • 6. Biological fate of butylated hydroxytoluene (BHT): binding of BHT metabolites to cysteine in vitro.
    Nakagawa Y; Hiraga K; Suga T
    Biochem Pharmacol; 1981 Apr; 30(8):887-90. PubMed ID: 7247969
    [No Abstract]   [Full Text] [Related]  

  • 7. Formation of a glutathione conjugate from butylated hydroxytoluene by rat liver microsomes.
    Tajima K; Yamamoto K; Mizutani T
    Biochem Pharmacol; 1985 Jun; 34(12):2109-14. PubMed ID: 4004928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative metabolism of butylated hydroxytoluene by hepatic and pulmonary microsomes from rats and mice.
    Thompson JA; Malkinson AM; Wand MD; Mastovich SL; Mead EW; Schullek KM; Laudenschlager WG
    Drug Metab Dispos; 1987; 15(6):833-40. PubMed ID: 2893710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidation of butylated hydroxytoluene to toxic metabolites. Factors influencing hydroxylation and quinone methide formation by hepatic and pulmonary microsomes.
    Bolton JL; Thompson JA
    Drug Metab Dispos; 1991; 19(2):467-72. PubMed ID: 1676656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological fate of butylated hydroxytoluene (BHT)--binding of BHT to nucleic acid in vivo.
    Nakagawa Y; Hiraga K; Suga T
    Biochem Pharmacol; 1980 May; 29(9):1304-6. PubMed ID: 6156686
    [No Abstract]   [Full Text] [Related]  

  • 11. On the mechanism of covalent binding of butylated hydroxytoluene to microsomal protein.
    Nakagawa Y; Hiraga K; Suga T
    Biochem Pharmacol; 1983 Apr; 32(8):1417-21. PubMed ID: 6860361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Probable model of dibunol pharmacokinetics].
    Matveeva SA; Maksimov VM; Marshak IaI; Konradov AA; Barsel' VA
    Izv Akad Nauk SSSR Biol; 1979; (2):271-81. PubMed ID: 429681
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of 2,6-di-tert-butyl-4-methylene-2,5-cyclohexadienone (BHT quinone methide) in the metabolism of butylated hydroxytoluene.
    Takahashi O; Hiraga K
    Food Chem Toxicol; 1983 Jun; 21(3):279-83. PubMed ID: 6683224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced lung toxicity of butylated hydroxytoluene in mice by coadministration of butylated hydroxyanisole.
    Yamamoto K; Tajima K; Okino N; Mizutani T
    Res Commun Chem Pathol Pharmacol; 1988 Feb; 59(2):219-31. PubMed ID: 3358012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of promutagen activation by the antioxidants butylated hydroxyanisole and butylated hydroxytoluene.
    McKee RH; Tometsko AM
    J Natl Cancer Inst; 1979 Aug; 63(2):473-7. PubMed ID: 287836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of pretreatment with butylated hydroxytoluene (BHT) on binding of 14C-BHT to lung microsomes.
    Nakagawa Y; Hiraga K; Suga T
    J Pharmacobiodyn; 1980 Jun; 3(6):314-6. PubMed ID: 7420266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of butylated hydroxytoluene-mediated modulation of 2-acetylaminofluorene mutagenicity in rat and human hepatocyte/Salmonella assays.
    Chipman JK; Davies JE; Paterson P
    Mutat Res; 1987 Mar; 187(3):105-12. PubMed ID: 3547109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of butylated hydroxytoluene and butylated hydroxyanisole on the mutagenicity of 3,2'-dimethyl-4-aminobiphenyl.
    Reddy BS; Sharma C; Mathews L
    Nutr Cancer; 1983; 5(3-4):153-8. PubMed ID: 6366755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A metabolite of butylated hydroxytoluene with potent tumor-promoting activity in mouse lung.
    Thompson JA; Schullek KM; Fernandez CA; Malkinson AM
    Carcinogenesis; 1989 Apr; 10(4):773-5. PubMed ID: 2702725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of butylated hydroxyanisole (BHA) and butylated hydroxytoluene (BHT) on metabolism of N,N-dimethyl-4-aminoazobenzene (DAB) by rat liver microsomes.
    Levine WG
    Res Commun Chem Pathol Pharmacol; 1984 Oct; 46(1):113-20. PubMed ID: 6438741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.